NASA’s ambitious Artemis program is making steady progress toward its goal of establishing a long-term human presence on the ...
Estrella Immunopharma, Inc. ("Estrella" or the "Company"), a clinical stage biopharmaceutical company developing CD19-targeted ARTEMIS® T-cell therapies to treat cancer and autoimmune diseases, today ...
NASA’s Artemis II mission is preparing to send astronauts back to the Moon for the first time in over 50 years. As part of ...
America's Artemis moon mission faces growing uncertainty as reports suggest Trump’s potential return to power and Musk’s influence could shift NASA’s focus toward Mars instead of the Moon. Originally ...
President Trump launched the Artemis program to return U.S. astronauts to the moon for the first time since Apollo. Now, the plan could be a casualty of the cost-cutting drive overseen by Elon Musk.
Boeing notified employees it is planning to issue layoff notices "to align with revisions to the Artemis program and cost expectations." ...